Pfizer is letting go an undisclosed number of employees and ending research operations at its site in Boulder, CO, the company confirmed to Endpoints News.
The site came to Pfizer through its $11.4 billion acquisition of Array BioPharma in 2019. At one point, it employed almost 300 people, according to Pfizer’s website. The move comes a year after Pfizer said it would look to “externalize” research at the location.
“Although we received some investor interest through this process, we have made the difficult decision to wind down Boulder research operations by the end of Q2 2024,” a spokesperson told Endpoints Monday. “Pfizer will retain a site presence in Boulder for colleagues not affiliated with our research activities to continue working.”
Last week, several people who worked at the site said in LinkedIn posts that they’d been let go and research work was being shut down, according…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
